Although CLS formation has been reported to be positively correlated with M1 macrophages, increased severity of obesity and metabolic syndrome, these studies identify Trem2+ CLSs as a new potential therapeutic target in obesity. The gene discussed is TREM2; the disease is obesity due to melanocortin 4 receptor deficiency.